In the BioHarmony Drug Report Database

"Preview" Icon

Deslanoside

Cedilanid-d (deslanoside) is a small molecule pharmaceutical. Deslanoside was first approved as Cedilanid-d on 1982-01-01. It is used to treat atrial fibrillation, atrial flutter, heart failure, low cardiac output, and supraventricular tachycardia in the USA. The pharmaceutical is active against sodium/potassium-transporting ATPase subunit alpha-1.

 

Trade Name

 

Cedilanid-d
 

Common Name

 

deslanoside
 

ChEMBL ID

 

CHEMBL1614
 

Indication

 

atrial fibrillation, atrial flutter, heart failure, low cardiac output, supraventricular tachycardia
 

Drug Class

 

Image (chem structure or protein)

Deslanoside structure rendering